192 results on '"Weismüller, Tobias J."'
Search Results
2. Evaluation of Tofacitinib in Primary Sclerosing Cholangitis and Associated Colitis: A Multicenter, Retrospective Study
3. Myosteatosis independently predicts transplant-free survival in patients with primary sclerosing cholangitis
4. Management of esophageal perforations in infants by endoscopic vacuum therapy: a single center case series
5. Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy
6. Non-invasive assessment of liver fibrosis in autoimmune hepatitis: Diagnostic value of liver magnetic resonance parametric mapping including extracellular volume fraction
7. Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells
8. Management of post-operative pancreatic fistulas following Longmire–Traverso pylorus-preserving pancreatoduodenectomy by endoscopic vacuum-assisted closure therapy
9. Transpapillary tissue sampling of biliary strictures: balloon dilatation prior to forceps biopsy improves sensitivity and accuracy
10. Comparison between regular additional endobiliary radiofrequency ablation and photodynamic therapy in patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy.
11. Endoscopic papillectomy for ampullary lesions in patients with familial adenomatous polyposis compared with sporadic lesions: a propensity score-matched cohort.
12. No Evidence That Azathioprine Increases Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis
13. Low Risk of Hepatocellular Carcinoma in Patients With Primary Sclerosing Cholangitis With Cirrhosis
14. Risk estimation for biliary tract cancer: Development and validation of a prognostic score
15. Impact on follow‐up strategies in patients with primary sclerosing cholangitis.
16. Alveolar Echinococcosis in a Patient with Presumed Autoimmune Hepatitis and Primary Sclerosing Cholangitis: An Unexpected Finding after Liver Transplantation.
17. Medical and endoscopic therapy of primary sclerosing cholangitis
18. Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis
19. Genome-Wide Association Analysis in Primary Sclerosing Cholangitis
20. Double is not always better: rare cause of chronic pain and weight loss in an Asian female patient with an anomaly of the bile duct system
21. A pocket guide to identify patients at risk for chronic kidney disease after liver transplantation
22. Model for end-stage liver disease underestimates mortality of patients with acute-on-chronic liver failure waiting for liver transplantation.
23. Gadoxetate disodium in patients with primary sclerosing cholangitis: An analysis of hepatobiliary contrast excretion
24. Genome-Wide Association Analysis in Primary Sclerosing Cholangitis And Ulcerative Colitis Identifies Risk Loci at Gpr35 And Tcf4
25. Screening colonoscopy in liver transplant candidates: risks and findings
26. Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders
27. Primary sclerosing cholangitis with moderately elevated serum‐IgG4 – characterization and outcome of a distinct variant phenotype.
28. First Line and Second Line Chemotherapy in Advanced Cholangiocarcinoma and Impact of Dose Reduction of Chemotherapy: A Retrospective Analysis.
29. Serum ferritin concentration and transferrin saturation before liver transplantation predict decreased long-term recipient survival
30. Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9
31. Bile Proteomic Profiles Differentiate Cholangiocarcinoma From Primary Sclerosing Cholangitis and Choledocholithiasis§Δ
32. Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany – limitations of the ‘sickest first’-concept
33. Serum ferritin concentration and transferrin saturation before liver transplantation predict decreased long-term recipient survival
34. Ferritin and Liver Allocation? Impact on Mortality Not Only on the Waiting List But Also After Orthotopic Liver Transplantation Should Be Considered
35. The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics
36. Ruxolitinib for treatment of polycythemia vera and myelofibrosis in patients after liver transplantation.
37. Intensified Endoscopic Evaluation for Biliary Complications After Orthotopic Liver Transplantation.
38. Role of Intraductal RFA: A Novel Tool in the Palliative Care of Perihilar Cholangiocarcinoma.
39. Variation in Bile Microbiome by the Etiology of Cholestatic Liver Disease.
40. Genetic variants of UDP‐glucuronosyltransferase 1A genes are associated with disease presentation and outcome in primary sclerosing cholangitis.
41. Combined photodynamic therapy with systemic chemotherapy for unresectable cholangiocarcinoma.
42. Endoscopic Ultrasound-Guided Drainage and Treatment of Symptomatic Pancreatic Fluid Collection following Acute or Acute-on-Chronic Pancreatitis – A Single Center Case Series.
43. Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.
44. Transcutaneous vagal nerve stimulation improves gastroenteric complaints in Parkinson's disease patients.
45. Primär sklerosierende Cholangitis.
46. Double is not always better: rare cause of chronic pain and weight loss in an Asian woman with an anomaly of the bile duct system.
47. Criteria Used in Clinical Practice to Guide Immunosuppressive Treatment in Patients with Primary Sclerosing Cholangitis.
48. Disturbed hepatic sulfation capacity: another piece of the puzzle in the complex pathogenetic mechanism of primary sclerosing cholangitis?
49. Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis.
50. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.